MiR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells

Clinical and Investigative Medicine

Volumn 34, Issue 5, 2011, Pages

  Lou, Yanhui ^a   Cui, Zhumei ^a   Wang, Fuling ^a   Yang, Xingsheng ^b   Qian, Jinhua ^a  

^a QINGDAO UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84861489369     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews 2004; 5: 522-531.
2. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 2999-3004.
3. Akao Y, Nakagawa Y, Naoe T: let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biological & pharmaceutical bulletin 2006; 29: 903-906.
4. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
5. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, et al.: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer research 2008; 68: 425-433.
6. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, et al.: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402.
7. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY: miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
8. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658.
9. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al.: MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-2136.
10. Zhu S, Si ML, Wu H, Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). fie Journal of biological chemistry 2007; 282: 14328-14336.
11. Lou YH, Yang XS, Wang FL, Qian JH, Huang Y: [Expression of microRNA-21 in ovarian epithelial carcinoma and its clinical significance]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University; 30: 608-610, 613.
12. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
13. Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
14. Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer research 2005; 65: 6029-6033.
15. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer research 2007; 67: 8994-9000.
16. Chang K, Elledge SJ, Hannon GJ: Lessons from Nature: microRNA-based shRNA libraries. Nature methods 2006; 3: 707-714.
17. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000; 100: 57-70.
18. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell research 2008; 18: 350-359.
19. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I: Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003, 200:640-646.
20. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH: Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004, 23:8135-8145.
21. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK, Ngan HY: Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 2009, 8:70.
22. Frankel L B, Christoffersen N R, Jacobsen A, et al. Programmed cell death 4 (Pdcd4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem, 2008, 283(2): 1026-103
23. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y: Microrna-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene.2008, 27:4373-4379.
24. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH: The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003, 23:26-37.
25. Waters LC, Veverka V, Bohm M, Schmedt T, Choong PT, Muskett FW, Klempnauer KH, Carr MD: Structure of the Cterminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A. Oncogene 2007, 26:4941-4950.
26. Wang Q, Sun Z, Yang HS: Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008, 27:1527-1535.
27. Lou YH, Yang XS, Wang FL, Cui ZM and Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010, 26: 819-827.